NEW YORK, July 24 - Affymetrix has hired Trevor Nicholls to be its first chief commercial officer of global operations, said Affymetrix president, Susan Siegel.
Nicholls, who will be responsible for leading Affy's global sales, marketing, and manufacturing operations, was founder and CEO of Oxagen Limited, a UK-based clinical genomics company. He was replaced at Oxagen earlier this month by Mark Payton, former VP of gene and target portfolio, genetics research at GlaxoSmithKline. When Oxagen announced Payton's appointment on July 10, it said that Nicholls would remain in the CEO post "for some months in order to effect a smooth handover."
Before founding Oxagen, Nicholls served as the commercial director of the life science business of Amersham International.